IGC Pharma (IGC) Proxy filing summary

Executive summary

• Annual meeting scheduled for December 2, 2026; proxy voting deadline is December 1, 2026 at 11:59 p.m. ET.

Voting matters and shareholder proposals

• Ballot includes Claudia Grimaldi’s election, two incentive-plan amendments, approval of a 5,000,000-share grant, say-on-pay, auditor ratification, and an adjournment proposal.

• Incentive-plan amendments would move the annual reserve adjustment date from April 1 to January 1 and raise the reserve percentage from 15% to 20%, both effective January 1, 2027; For votes are recommended.

• Approval sought for 5,000,000 common shares to be granted over time to current and new employees, officers, advisors, directors, and consultants, subject to Board- or CEO-set metrics; For vote recommended.

• Shareholders are asked to ratify Manohar Chowdhry & Associates for FY ending December 31, 2026, and may vote on adjournment or postponement to allow further proxy solicitation.

Board of directors and corporate governance

• Claudia Grimaldi is nominated as a Class A director through the 2029 annual meeting, until a successor is elected and qualified or her earlier death, resignation, or removal; Board recommends For.